news
Denosumab Included in Russian Ministry of Health Clinical Guidelines for the Treatment of Osteonecrosis
The Russian Ministry of Health has included denosumab in its clinical guidelines for the treatment of aseptic bone necrosis (osteonecrosis)[1]. The medicine is recommended as part of comprehensive treatment, including for patients in whom the use of bisphosphonates is limited. Previously, prescribing antiresorptive therapy for osteonecrosis required a decision by a medical commission. Its inclusion in the updated clinical guidelines expands treatment options for the disease.
Petrovax Pharm will export Polyoxidonium® tablets to Slovakia
Reducing the years-long wait for innovative treatments: experts discussed solutions at BIOPROM-26
Petrovax Pharm presents new biotech medicines at BIOPROM-26
An original medicine for the targeted treatment of ovarian and HER2-negative breast cancer is authorized in Russia
A unified care pathway and immune status: experts discussed new approaches to pneumonia management
Russia’s Ministry of Health approves the country’s first domestically produced quadrivalent meningococcal vaccine
The risks of putting it off: experts discussed the link between prostatitis and men’s sexual and reproductive health
A look at the future of innovative therapy: Petrovax Pharm introduces young people to the modern biopharmaceutical industry
